Global /China /Healthcare /Drug Manufacturers - Specialty & Generic /3737

Zhongzhi Pharmaceutical Holdings Ltd.

3737

• SHEK: 3737 • Delayed

0.8100HKD 0%

0.1034 USD

As of 6 June 2026, Zhongzhi Pharmaceutical Holdings Ltd. has a market cap of $89.28M USD, ranking #26363 globally and #5948 in China. It ranks #2363 in the Healthcare sector, and #125 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

26363

Country Rank

5948

Sector Rank

2363

Industry Rank

125

Key Stats

Market Cap

$89.28MUSD

699.52M HKD

Enterprise Value

$80.21MUSD

628.46M HKD

Revenue (TTM)

$246.77MUSD

1.93B HKD

EBITDA (TTM)

$7.85MUSD

61.52M HKD

Net Income (TTM)

$2.46MUSD

19.24M HKD

EBITDA Margin

3.2%

Profit Margin

PE Ratio

36.4

PS Ratio

0.4

PB Ratio

0.6

EV/EBITDA

5.8

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Ying Feng Lai open_in_new

Employees

2,284

Founded

1993

Website

zeus.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-3.6%	-4.7%	14%	33%	45%	-11%	-28%	-42%

News

Markets

Exchange	Ticker	Price	Quotes
Hong Kong Stock Exchange (SHEK / HKEX) MIC: XHKG PRIMARY	3737 中智药业控股有限公司 ISIN: KYG989611085 Shares Out.: Shares Outstanding: 843.745M¹ Shares Float: 282.055M² TV: TradingView: HKEX: 3737 SA: Stock Analysis: HKG: 3737 YF: Yahoo Finance: 3737.HK GF: Google Finance: HKG: 3737 BA: Barron's: 3737 MS: Morningstar: XHKG: 03737	0.8100 HKD	TV: TradingView: HKEX: 3737 SA: Stock Analysis: HKG: 3737 YF: Yahoo Finance: 3737.HK GF: Google Finance: HKG: 3737 BA: Barron's: 3737 MS: Morningstar: XHKG: 03737

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Zhongzhi Pharmaceutical Holdings Ltd.

Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China. The company operates through Pharmaceutical Manufacturing and Operation of Chain Pharmacies segments. It also provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brand names. In addition, the company manufactures and sells food and Chinese herbs; offers detection and testing services; and manages properties. Further, the company engages in the wholesale of pharmaceutical products; and provision of traditional Chinese medicine service. Zhongzhi Pharmaceutical Holdings Limited was founded in 1993 and is headquartered in Zhongshan, the People’s Republic of China. Zhongzhi Pharmaceutical Holdings Limited is a subsidiary of Crystal Talent Investment Group Limited.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (China)

Name	Market Cap (USD) diff.	PE	Country
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 18K%	16.0	China
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 10K%	80.6	China
Dong-E-E-Jiao Co., Ltd. SHE: 000423	$5.22B 35.33B CNY 6K%	20.0	China
Shijiazhuang Yiling Pharmaceutical Co., Ltd. SHE: 002603	$4.21B 28.47B CNY 5K%	20.8	China
Jilin Aodong Pharmaceutical Group Co., Ltd. SHE: 000623	$3.27B 22.12B CNY 4K%	8.1	China
China Resources Double-Crane Pharmaceutical Co.,Ltd. SSE: 600062	$2.74B 18.55B CNY 3K%	11.5	China

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 42K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 33K%	-	United States
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 12K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 12K%	22.7	India
ABIVAX Société Anonyme EPA: ABVX	$8.79B 7.57B EUR 10K%	-	France
Aurobindo Pharma Ltd. NSE: AUROPHARMA	$8.43B 807.02B INR 9K%	23.1	India

chevron_leftBack